
    
      A Phase I, Single Center and Open Label Study to Assess the Safety and Pharmacokinetics of
      Ceftaroline in Healthy Chinese Volunteers Following Single and Multiple Administration of 600
      mg Ceftaroline Fosamil as 60-minute Intravenous Infusion Every 12 hours and as 120-minute
      Intravenous Infusion Every 8 hours.
    
  